Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend Dec 17, 2014 05:45PM
Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis Dec 11, 2014 04:01PM
Amgen Presents Data From Pivotal Phase 2 Study Of BLINCYTO™ (blinatumomab) Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Dec 8, 2014 09:00PM
New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA® (Pembrolizumab) For Advanced Melanoma Dec 8, 2014 04:20PM
FDA Approves Amgen's XGEVA® (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy Dec 8, 2014 09:00AM

Dec 6, 2014 01:00PM Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Dec 6, 2014 11:00AM Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
Dec 3, 2014 07:00PM Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition
Dec 3, 2014 04:30PM Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources
Dec 3, 2014 03:48PM FDA Approves BLINCYTO™ (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Nov 25, 2014 04:01PM Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Nov 24, 2014 09:15AM Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
Nov 18, 2014 04:00PM Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels
Nov 14, 2014 04:15PM Amgen To Present At The Jefferies Global Healthcare Conference
Nov 12, 2014 04:35PM Amgen To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions
Nov 12, 2014 04:01PM Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab
Nov 12, 2014 09:00AM The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide
Nov 11, 2014 04:01PM Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Nov 10, 2014 09:15AM FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Nov 6, 2014 04:30PM Amgen To Present At The Credit Suisse Annual Healthcare Conference
Nov 6, 2014 04:01PM Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014
Nov 4, 2014 09:00AM Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer
Oct 28, 2014 09:33AM Pre-Open Stock Movers 10/28: (RCPT) (TRNX) (VDSI) (MSG) Higher; (TWTR) (AMKR) (CVLT) Lower (more...)
Oct 28, 2014 08:48AM Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans
Oct 27, 2014 06:22PM After-Hours Stock Movers 10/27: (TRNX) (RCPT) (SANM) Higher; (AKMR) (TWTR) (KSS) Lower (more...)
Oct 27, 2014 04:01PM Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30
Oct 23, 2014 05:39PM Amgen To Webcast 2014 Business Review Meeting On October 28
Oct 23, 2014 04:05PM Amgen Announces Webcast of 2014 Third Quarter Financial Results
Oct 21, 2014 03:41PM Amgen Statement Regarding Third Point Investment
Oct 17, 2014 04:17PM Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors
Oct 17, 2014 04:03PM Amgen Announces 2014 Fourth Quarter Dividend
Oct 17, 2014 09:00AM Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Oct 14, 2014 10:03AM UPDATE: Gilead Sciences (GILD) Hits Session Lows
Oct 9, 2014 04:05PM Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia
Oct 8, 2014 09:15AM Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psor
Oct 1, 2014 07:01PM The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol
Oct 1, 2014 04:01PM Amgen Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology
Sep 24, 2014 05:02PM Amgen to Host Summary Webcast of Kyprolis® (carfilzomib) for Injection Data Presented at The European Society for Medical Oncology (ESMO) 2014 Congress
Sep 22, 2014 09:00AM Amgen Submits Biologics License Application for Investigational BiTE® Immunotherapy Blinatumomab
Jul 30, 2014 10:29AM Top 10 Trending Stocks for 07/30: Twitter (TWTR), Amgen (AMGN), Regeneron (REGN), and More...
Jul 30, 2014 09:32AM Pre-Open Stock Movers 7/30: (GFIG) (TWTR) (NQ) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
Jul 29, 2014 06:10PM After-Hours Stock Movers 7/29: (TWTR) (ZLTQ) (X) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
Jul 29, 2014 05:37PM Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple
Jul 28, 2014 05:11PM Trading Radar for 07/29: Pfizer (PFE), Marriott (MAR), UPS (UPS), Anadarko (APC), Ballard Power (BLDP) Report